Frederic Robert

Title: Frederic Robert: Innovator in Capillary Electrophoresis

Introduction

Frederic Robert is a notable inventor based in France, recognized for his contributions to the field of capillary electrophoresis. His work primarily focuses on the analysis of glycated hemoglobins, which are crucial for understanding various medical conditions, including diabetes. With a commitment to innovation, Frederic has developed methods that enhance the accuracy and efficiency of hemoglobin analysis.

Latest Patents

Frederic Robert holds two significant patents related to his work in capillary electrophoresis. The first patent, titled "Analyse Et Dosage D'hemoglobines Glyquees Par Electrophorese Capillaire," describes a method for analyzing glycated hemoglobins using a buffer composition that specifically complexes glucose residues. This method allows for the separation and quantification of HbA1c hemoglobin in biological samples. The second patent, "Procede D`analyse De L`hemoglobine Par Electrophorese Capillaire," outlines a capillary electrophoresis process that utilizes a zwitterionic buffer and flow inhibitors to improve the analysis of hemoglobin samples.

Career Highlights

Frederic Robert is currently employed at Sebia, a company known for its expertise in laboratory diagnostics. His work at Sebia has allowed him to apply his innovative methods in a practical setting, contributing to advancements in medical diagnostics. Despite having no patents attributed to him, his research and development efforts have significantly impacted the field.

Collaborations

Frederic has collaborated with esteemed colleagues, including Denis Simonin and Gerald Deschamps. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Frederic Robert is a dedicated inventor whose work in capillary electrophoresis has the potential to transform medical diagnostics. His innovative methods for analyzing glycated hemoglobins demonstrate his commitment to advancing healthcare technology.